These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6001925)

  • 1. [On the study of inhibitor of factor VIII in patients with hemophilia A].
    Papaian-Pokrysheva LP
    Probl Gematol Pereliv Krovi; 1966 Nov; 11(11):46-8. PubMed ID: 6001925
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
    de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
    Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor to factor VIII in mild haemophilia.
    Lowe GD; Forbes CD
    Thromb Haemost; 1985 Feb; 53(1):159. PubMed ID: 3922079
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII inhibitor and severity of hemophilia.
    Schoppmann A; Waytes AT
    Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Circulating anticoagulant in hemophilia A: laboratory evidence of a coagulation factor 8 inhibitor].
    Hule V
    Vnitr Lek; 1967 Sep; 13(9):859-65. PubMed ID: 6081657
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
    Guérois C; Laurian Y; Rothschild C; Parquet-Gernez A; Duclos AM; Négrier C; Vicariot M; Fimbel B; Fressinaud E; Fiks-Sigaud M
    Thromb Haemost; 1995 Feb; 73(2):215-8. PubMed ID: 7792732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor VIII, factor VIII inhibitor].
    Takamatsu J
    Nihon Rinsho; 1999 Sep; 57 Suppl():604-6. PubMed ID: 10543190
    [No Abstract]   [Full Text] [Related]  

  • 12. [Appearance of a factor VIII inhibitor during the postoperative period in two non-hemophiliacs].
    Lévy G; Juhan I; Calas-Aillaud MF; Granthil G; Martin C; Verdot JJ; François G
    Ann Anesthesiol Fr; 1980; 21(5):545-9. PubMed ID: 6109504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transient inhibitors developed in two cases of hemophilia A].
    Fujiwara F; Kanoh G; Ogawa H; Takaya K; Hibi S; Shima M; Yoshioka A; Imashuku S
    Rinsho Ketsueki; 1997 Dec; 38(12):1263-8. PubMed ID: 9455145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative effects of the reaction between factor VIII and factor VIII inhibitors.
    McMillan CW; Elston RC
    Thromb Diath Haemorrh; 1971 Aug; 26(1):124-34. PubMed ID: 5112370
    [No Abstract]   [Full Text] [Related]  

  • 15. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
    Peerlinck K; Arnout J; Gilles JG; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1993 Feb; 69(2):115-8. PubMed ID: 8456422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.
    Pascual V; Capra JD
    J Clin Invest; 1996 Mar; 97(6):1357-8. PubMed ID: 8617864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of inhibitors in children with hemophilia A].
    Izquierdo-Ramírez J; Contreras-Mulato EL; Sotelo-Ham EI; Marín-Palomares T; Dueñas-González MT; Benítez-Aranda H
    Bol Med Hosp Infant Mex; 1988 Sep; 45(9):578-82. PubMed ID: 3142496
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationships of factor VIII (antihemophilic globulin) and its weak inhibitors with the spleen. Effect of adrenaline on splenectomized subjects, on splenomegaly and on patients presenting a weak factor VIII inhibitor].
    Mayer G; Kalogjera V; Oberling F; Mayer S; Waitz R
    Haematol Lat; 1971; 13(3):185-206. PubMed ID: 5097059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulating anticoagulants in hemophilia A].
    Michalski R; Lopaciuk S
    Acta Haematol Pol; 1973; 4(3):203-9. PubMed ID: 4800573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.